Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection
Tropical Medicine and Infectious Disease·
- DOI
- 10.3390/tropicalmed11090244
- PMID
- —
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- MDPI AG
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The article frames precision vaccinology as relevant to mpox preparedness and development of vaccines intended to provide durable, clade-specific protection. The supplied abstract does not provide clinical effectiveness estimates or outcome data supporting a specific public health intervention.
Structured evidence summary
Research question
How can antigen selection, vaccine delivery platforms, and immune correlates of protection inform next-generation mpox vaccine development?
Study design
This is a review article synthesizing evidence on mpox antigen design, vaccine platforms, and immunological correlates of protection. It is not presented as a primary clinical or epidemiological study.
Population and setting
The review concerns mpox vaccination and vaccine development in a global public health and outbreak-preparedness context. The supplied abstract does not define a specific enrolled population, geographic study site, or clinical setting.
Main findings
The review identifies conserved immunodominant antigens from mature and extracellular virion forms as a basis for multivalent vaccine designs intended to generate broad neutralizing-antibody responses. It discusses mRNA-lipid nanoparticles, viral vectors, and self-assembling protein nanoparticles as emerging delivery approaches, while identifying antigenic evolution, supply constraints, and population-specific immune variability as issues for vaccine optimization.
Public-health relevance
The article frames precision vaccinology as relevant to mpox preparedness and development of vaccines intended to provide durable, clade-specific protection. The supplied abstract does not provide clinical effectiveness estimates or outcome data supporting a specific public health intervention.
Important limitations
The supplied abstract does not state detailed review methods, eligibility criteria, or a formal assessment of the underlying evidence, and it does not provide primary participant-level results. This summary is limited to the supplied single-article abstract and metadata; the original paper is required for decision-grade interpretation.
GIDS interpretation
The article is discoverable in the supplied metadata under Monkeypox, Vaccination, and Vaccine effectiveness. It provides contextual literature on mpox vaccine design and protection correlates, but the supplied evidence does not connect its findings to a live surveillance signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.